Bryan D Smith Selected Research

Bryan D Smith Research Topics

Disease

11	Neoplasms (Cancer) 03/2024 - 09/2011
4	Neoplasm Metastasis (Metastasis) 11/2021 - 09/2015
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2017 - 04/2011
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2021 - 01/2019
1	Bites and Stings (Sting) 03/2024
1	Carcinogenesis 02/2024
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024
1	Lung Neoplasms (Lung Cancer) 02/2024
1	Giant Cell Tumor of Tendon Sheath 10/2022
1	Giant Cell Tumors (Giant Cell Tumor) 11/2021
1	Systemic Mastocytosis 01/2021
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2017
1	Carcinoma (Carcinomatosis) 11/2017
1	Breast Neoplasms (Breast Cancer) 11/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2016
1	Brain Neoplasms (Brain Tumor) 09/2015
1	Melanoma (Melanoma, Malignant) 05/2015
1	Leukemia 04/2011
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2011

Drug/Important Bio-Agent (IBA)

8	Phosphotransferases (Kinase)IBA 03/2024 - 04/2011
2	Proteins (Proteins, Gene)FDA Link 03/2024 - 09/2011
2	ripretinibIBA 01/2021 - 01/2019
2	rebastinibIBA 11/2017 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2017 - 09/2015
2	Tyrosine Kinase InhibitorsIBA 01/2017 - 04/2011
2	LY3009120IBA 09/2015 - 05/2015
2	DCC-2036IBA 05/2011 - 04/2011
1	Small Interfering RNA (siRNA)IBA 03/2024
1	InterferonsIBA 03/2024
1	Interferon Type IIBA 03/2024
1	Programmed Cell Death 1 ReceptorIBA 03/2024
1	B7-H1 AntigenIBA 03/2024
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 03/2024
1	LipidsIBA 03/2024
1	ChemokinesIBA 03/2024
1	CytokinesIBA 03/2024
1	sotorasibIBA 02/2024
1	adagrasibIBA 02/2024
1	Oncogene Proteins (Oncogene Protein)IBA 02/2024
1	compound 20IBA 10/2022
1	pexidartinibIBA 11/2021
1	Macrophage Colony-Stimulating FactorIBA 11/2021
1	AntibodiesIBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2017
1	eribulin FDA Link 11/2017
1	AngiopoietinsIBA 11/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2017
1	Adenosine (Adenocard)FDA LinkGeneric 01/2017
1	Bevacizumab (Avastin)FDA Link 01/2016
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2016
1	Protein Isoforms (Isoforms)IBA 09/2015
1	VemurafenibIBA 05/2015
1	Urea (Carbamide)FDA LinkGeneric 05/2015
1	dabrafenibIBA 05/2015
1	Folic Acid (Vitamin M)FDA LinkGeneric 09/2011

Therapy/Procedure

4	Therapeutics 03/2024 - 05/2011
1	Immunotherapy 03/2024
1	Drug Therapy (Chemotherapy) 11/2017
1	Oral Administration 09/2015